OR WAIT null SECS
Patricia Van Arnum was executive editor of Pharmaceutical Technology.
July 01, 2010
The Office of the Inspector General for the Department of Health and Human Services (HHS) issued a report, Challenges to FDA's Ability to Monitor and Inspect Foreign Clinical Trials, which evaluates the incidence of foreign clinical trials, the ability of the US Food and Drug Administration to oversee these trials, and recommendations to FDA on how to improve its oversight of foreign clinical trials.
June 24, 2010
The US International Trade Commission (USITC), an independent federal agency, is initiating a review of more than 700 pharmaceutical products and chemical intermediates to be considered for duty elimination.
June 17, 2010
The Critical Path Institute announced last week the formation of the Coalition Against Major Diseases, a formal consortium of pharmaceutical companies, research foundations, patient-advocacy groups, health organizations, and regulatory agencies, which will share information on clinical trials for treatments for neurodegenerative diseases.
June 10, 2010
Pfizer (New York) is voluntarily recalling metronidazole, ciprofloxacin, and ondansetron intravenous products because of the presence of floating matter and non-sterility discovered by the manufacturer Claris Lifesciences.
June 09, 2010
The pharmaceutical industry provided immediate aid for the relief efforts in Haiti and is proceeding with plans to assist with long-term recovery.
FDA issues draft proposals on ways to improve its disclosure on information relating to import procedures, inspections, and Warning Letters.